ALFA Filings
Every announcement, straight from the exchange
Every Jagsonpal Pharmaceuticals financial results announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Jagsonpal Pharmaceuticals Ltd reported revenue from operations of ₹81.4 Cr (+9.3% YoY) and net profit of ₹12.6 Cr (+0.0% YoY) for Q2 FY27.
Jagsonpal Pharmaceuticals Ltd reported revenue from operations of ₹82.2 Cr (+8.7% YoY) and net profit of ₹13.2 Cr (+22.2% YoY) for Q1 FY27.
Jagsonpal Pharmaceuticals Ltd reported revenue from operations of ₹64.2 Cr (+9.6% YoY) and net profit of ₹8.8 Cr (+33.3% YoY) for Q4 FY26.
Jagsonpal Pharmaceuticals reported FY26 total income of ₹299.22 Crore and Net Profit of ₹43.08 Crore. The Board recommended a dividend of ₹4 (200%) per equity share. Additionally, a buy-back of up to 16,00,000 equity shares at ₹250 per share was previously approved, totaling ₹40 Crore.
Jagsonpal Pharmaceuticals Ltd reported net profit of ₹11 Cr (-65.6% YoY) for Q3 FY26.